Cannabis stocks rocked as FDA warning undermines case for CBD investments

Because the FDA has approved a drug that contains the ingredient – GW Pharmaceutical’s GWPH, +0.74% Epidiolex, a treatment for severe forms of childhood epilepsy – it told companies that they could …